Riskpilot← Back to searchSign inGet full accessSurgiCare Sverige AB
ABActiveOrg 5593051526Fortunavägen 13Medical specialists activities · NACE 8622Est. 20211 employees
Revenue 2025
SEK 634K
-31% vs 2024
EBITDA margin
378.5%
+247% vs 2024
Equity ratio
93.1%
Financial strength
Net profit 2025
SEK 2,4M
+229% vs 2024
| Revenue | SEK 634K | -31% |
| EBITDA | SEK 2,4M | +247% |
| Net profit | SEK 2,4M | +229% |
| Total assets | SEK 2,6M | +12% |
| Equity | SEK 2,4M | +8348% |
| Employees | 1 | — |
Legal name
SurgiCare Sverige AB
Org number
5593051526
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
3 mars 2021
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-02-28
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva kirurgisk mottagning med inriktning mot endoskopi och behandling av åderbråck samt därmed förenlig verksamhet.
Address
Fortunavägen 13
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 915 | 634 |
| Staff expenses | — | −110 | −914 | −230 |
| EBITDA | −2 | −376 | −1 635 | 2 398 |
| Depreciation & amort. | — | −164 | −219 | — |
| EBIT | −2 | −540 | −1 854 | 2 398 |
| Net financials | — | — | 0 | −0 |
| Profit before tax | −2 | −540 | −1 854 | 2 398 |
| Tax | — | — | — | −2 |
| Net profit | −2 | −540 | −1 854 | 2 396 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 23 | 4 738 | 2 322 | 2 604 |
| Equity | 23 | 183 | 29 | 2 425 |
| Long-term debt | — | — | — | — |
| Short-term debt | — | 4 555 | 2 293 | 179 |
| Total debt | — | 4 555 | 2 293 | 179 |
EBITDA margin
378.5%
This company
15.8%
Market median
+2296% vs market
20222025
Equity ratio
93.1%
This company
38.2%
Market median
+144% vs market
20222025
Return on equity
98.8%
This company
18.4%
Market median
+437% vs market
20222025
Net profit margin
378.2%
This company
8.1%
Market median
+4569% vs market
20222025
Asset turnover
0.24×
This company
1.12×
Market median
-79% vs market
20222025
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-03-01 – 2025-02-28
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-03-01 – 2024-02-29
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-03-01 – 2023-02-28
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-03-03 – 2022-02-28
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
CA | Audit | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Former (3) | ||
| Deputy Board Member | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SurgiCare Sverige AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Curt Arne Jesper Ahlkvist | Audit | 0 companies |
| Tommy Rickard Nilsson | Deputy Board Member | 0 companies |
| Michael Krzysztof Skowronski | Deputy Board Member | 0 companies |
| Caroline Therese Edvinsson | Board of Directors | 0 companies |
| Hanna Beatrice Maria Viebke | Deputy Board Member | 0 companies |
| Haytham Al-Tayar | Board of Directors | 0 companies |